KO Coca-Cola Co

Dividend
2.69%
Previous close
$76.72
Est. 12 months change
+10.68%
Projected Price
$85.00

Profitability Metrics

Return on Equity (ROE)
44.56%
Return on Assets (ROA)
10.90%
Return on Invested Capital (ROIC)
16.89%
Weighted Average Cost of Capital (WACC)
5.74%
ROIC - WACC
11.15%
Updated : 2026-04-03 21:14 ET

Valuation Metrics

P/E Ratio
25.24
Forward P/E
23.75
PEG Ratio
3.67
Debt Current Ratio
1.46

Growth & Cash Flow

Gross Margin
61.63%
Operating Margin
31.22%
FCF Margin
11.05%
TTM Revenue Growth
2.41%
Projected 12M EPS Growth
6.27%

Price Change

Price % from 50 SMA
-0.47%
Price % from 200 SMA
7.62%
6 Months
16.07%
1 Year
7.56%
2 Years
27.55%
Click here to see the list of ETFs containing KO as a top holding :Coca-Cola Co ETFs

Analysis

Company Overview

The Coca-Cola Company is the world's largest beverage company, producing and marketing carbonated soft drinks, juices, water, and energy drinks worldwide. Sector: Consumer Staples.

Overview

Coca-Cola Co (KO) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 16.89%, WACC is 5.74%, and the economic spread is 11.15%. On balance, the economic spread is positive and meaningful, suggesting the company are building rather than eroding intrinsic value. Supporting metrics show ROE at 44.56% and ROA at 10.90%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

Valuation

From a market pricing perspective, trailing P/E of 25.24, forward P/E of 23.75, PEG of 3.67. With trailing and forward P/E closely aligned, the market appears to be pricing the company on the assumption that earnings remain broadly stable near term. On a growth-adjusted basis, the company carries a premium valuation relative to its growth rate. The company carries an aggregate current ratio of 1.46, pointing to constrained near-term balance sheet coverage. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 61.63%, operating margin at 31.22%, and free cash flow margin at 11.05%. Gross margins at this level typically indicate businesses with structural pricing advantages and low direct cost sensitivity. At this level, operating margins reflect businesses with genuine scalability and above-average cost control. FCF margins are in a reasonable range, though there is room for improvement in how efficiently revenues convert to free cash. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

Growth & Forward Outlook

Where growth and expectations intersect, the estimated 12-month price change of 10.79%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 2.41% indicating muted but still positive top-line momentum across the company. Analyst estimates point to EPS growth of 6.3%, suggesting steady earnings progress that supports the current multiple on a forward basis. Both signals are useful lenses, but they tend to diverge most sharply near inflection points in both business fundamentals and market sentiment. The durability of both the operating trend and analyst optimism will determine whether the current setup translates into measurable near-term returns. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.